75 related articles for article (PubMed ID: 9236434)
1. Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Collaborative Organization for RheothRx Evaluation (CORE).
Circulation; 1997 Jul; 96(1):192-201. PubMed ID: 9236434
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group.
Maynard C; Swenson R; Paris JA; Martin JS; Hallstrom AP; Cerqueira MD; Weaver WD
Am Heart J; 1998 May; 135(5 Pt 1):797-804. PubMed ID: 9588408
[TBL] [Abstract][Full Text] [Related]
4. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
[TBL] [Abstract][Full Text] [Related]
5. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
6. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.
Ndrepepa G; Mehilli J; Martinoff S; Schwaiger M; Schömig A; Kastrati A
J Am Coll Cardiol; 2007 Jul; 50(2):149-56. PubMed ID: 17616299
[TBL] [Abstract][Full Text] [Related]
7. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
8. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
9. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
[TBL] [Abstract][Full Text] [Related]
11. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.
Toth K; Bogar L; Juricskay I; Keltai M; Yusuf S; Haywood LJ; Meiselman HJ
Clin Hemorheol Microcirc; 1997; 17(2):117-25. PubMed ID: 9255435
[TBL] [Abstract][Full Text] [Related]
12. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
13. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
14. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
15. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.
Pedersen OD; Bagger H; Køber L; Torp-Pedersen C;
Int J Cardiol; 2005 Apr; 100(1):65-71. PubMed ID: 15820287
[TBL] [Abstract][Full Text] [Related]
16. [Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].
Murena E; Molero U; Moio N; Pisani A; Stingone MA; Guardascione A; Grassia V; Scilla C; Marino A; Sibilio G
Ital Heart J Suppl; 2001 Jul; 2(7):775-82. PubMed ID: 11508296
[TBL] [Abstract][Full Text] [Related]
17. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
[TBL] [Abstract][Full Text] [Related]
18. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Berger JS; Stebbins A; Granger CB; Ohman EM; Armstrong PW; Van de Werf F; White HD; Simes RJ; Harrington RA; Califf RM; Peterson ED
Circulation; 2008 Jan; 117(2):192-9. PubMed ID: 18086929
[TBL] [Abstract][Full Text] [Related]
19. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
20. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
